Safety and Effectiveness of the Akreos Toric Intraocular Lens.

Bausch & Lomb Incorporated198 enrolled

Overview

The purpose of this study is to evaluate the safety and effectiveness of the Akreos Toric IOL following cataract surgery.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

198

Conditions

Cataract Astigmatism

Interventions

Akreos Toric IOLDEVICE

Lens implant following cataract surgery

Akreos Advanced Optics Aspheric Intraocular Lens (Akreos AO)DEVICE

Lens implant following cataract surgery

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects must be willing and able to provide written consent on the EC approved Informed Consent form. * Subjects must require a lens power from 15 to 30 diopters. Exclusion Criteria: * Subjects with any anterior segment pathology for which extracapsular phacoemulsification cataract surgery would be contraindicated. * Subjects with corneal pathology potentially affecting topography.

Locations (1)

Dept. of Clinical Sciences/ Ophthalmology Umea University Hospital

Umeå, Sweden

Outcomes

Primary Outcomes

Reduction of cylinder, Lens axis misalignment as determined by a photographic method.

Time frame: 32 months

Secondary Outcomes

Lens misalignment as determined by postoperative manifest refraction and vector analysis.

Time frame: 32 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.